Fate Therapeutics Inc (FATE) SEC Filings — 2025
11 SEC filings for Fate Therapeutics Inc (FATE) in 2025.
Filings
- Fate Therapeutics Narrows Losses Amid Restructuring, Revenue Dip — 10-Q · Nov 13, 2025
- Fate Therapeutics Files 8-K Report — 8-K · Oct 27, 2025
- Fate Therapeutics Announces CMO Departure and Interim Appointment — 8-K · Oct 14, 2025
- Fate Therapeutics Files 8-K on Financials and Operations — 8-K · Aug 12, 2025
- Fate Therapeutics' Q2 Loss Widens Amid R&D Surge — 10-Q · Aug 12, 2025
- Fate Therapeutics Files 8-K/A Amendment — 8-K/A · Jun 17, 2025
- Fate Therapeutics Files 8-K: Director Changes & Bylaw Amendments — 8-K · May 30, 2025
- Fate Therapeutics Q1 2025 Update — 10-Q · May 13, 2025
- Fate Therapeutics Executive Compensation Details — DEF 14A · Apr 17, 2025
- Fate Therapeutics Files 2024 10-K — 10-K · Mar 5, 2025
- Fate Therapeutics Files 8-K: Board & Compensation Updates — 8-K · Jan 6, 2025